Who holds AMLXAMYLYX PHARMACEUTICALS
9 funds on our shelf carry AMYLYX PHARMACEUTICALS — heaviest hand: XPH at 2.04% of its book.
| Fund | Weight | Fund assets | Shares held | |
|---|---|---|---|---|
| XPHState Street SPDR S&P Pharmaceuticals ETF | INDEX | 2.04% | $487M | 485,721 |
| IHEiShares U.S. Pharmaceuticals ETF | INDEX | 0.65% | $1.6B | 360,554 |
| DWASInvesco Dorsey Wright SmallCap Momentum ETF | INDEX | 0.34% | $411M | 48,603 |
| IBBQInvesco Nasdaq Biotechnology ETF | INDEX | 0.23% | $112M | 9,314 |
| VTWGVanguard Russell 2000 Growth ETF | INDEX | 0.22% | $1B | 113,140 |
| IBBiShares Biotechnology ETF | INDEX | 0.21% | $10.6B | 803,616 |
| IWOiShares Russell 2000 Growth ETF | INDEX | 0.19% | $14.4B | 969,505 |
| VFMOVanguard U.S. Momentum Factor ETF | INDEX | 0.17% | $646M | 120,117 |
| VHTVanguard Health Care Index Fund | INDEX | 0.04% | $19B | 267,729 |
LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS